|
|
|
|
|
|
|
AngioDynamics- Inc. (ANGO)
|
|
22.45 0.36 (1.63%)
|
06-20 16:00
|
|
Open:
|
22.13
|
Pre. Close:
|
22.09
|
|
High:
|
22.5
|
Low:
|
22.1
|
|
Volume:
|
176,823
|
Market Cap:
|
826M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
22.527 - 22.614
|
22.614 - 22.7
|
|
Low:
|
21.87 - 21.975
|
21.975 - 22.08
|
|
Close:
|
22.281 - 22.441
|
22.441 - 22.602
|
|
|
|
Technical analysis (as of: 2018-06-20 4:32:01 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 26.28  One year: 30.70
|
|
Support:
|
Support1: 20.50 Support2: 19.26
|
|
Resistance:
|
Resistance1:
22.50 Resistance2: 26.28
|
|
Pivot:
|
21.52
|
|
Moving Averages:
|
MA(5): 21.95 MA(20): 21.30
MA(100): 18.71 MA(250): 17.60
|
|
MACD:
|
MACD(12,26):
0.56 Signal(12,26,9): 0.51
|
|
%K %D:
|
%K(14,3): 95.42 %D(3): 93.67
|
|
RSI:
|
RSI(14): 80.50
|
|
52-Week:
|
High: 22.5
Low: 14.97 Change(%): 36.7
|
|
Average Vol(K):
|
3-Month: 22155
10-Days 17288
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.ANGO has closed above the upper band by 11.4%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 17.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-05-22T13:48:40-04:00
AngioDynamics (ANGO) Presents At 2018 UBS Global Healthcare Conference - Slideshow
2018-04-10T16:01:00-04:00
AngioDynamics to Present at Two Investor Conferences in May
2018-04-03T08:44:12-04:00
Premarket analyst action - healthcare
2018-04-02T13:09:06-04:00
AngioDynamics, Inc. 2018 Q3 - Results - Earnings Call Slides
2018-03-29T12:02:06-04:00
AngioDynamics' (ANGO) CEO Jim Clemmer on Q4 2018 Results - Earnings Call Transcript
2018-03-29T07:01:20-04:00
AngioDynamics beats by $0.06, misses on revenue
2018-03-29T07:00:00-04:00
AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results
2018-03-28T13:23:01-04:00
AngioDynamics (ANGO) Presents At Needham And Company 17th Annual Healthcare Conference - Slideshow
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
